Share Class
FR0010312660
Global equities - broad in perspective, selective by conviction
- An unconstrained approach in terms of sectors, regions, or investment style.
- Stock selection based on companies that excel, are undervalued, and display a long-term potential.
- Focus on secular growth profile driven by innovation, technology and a unique selling proposition.
Key documents
Asset Allocation
Equities96.6 %
Other3.4 %
Data as of: Jan 30, 2026.
Risk Indicator
1
2
3
4
5
6
7
Lowest risk
Highest risk
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
Cumulative Performance 10 YearsCumulative Performance 5 YearsCumulative Performance 3 YearsCumulative Performance 12 Months
+ 258.4 %
+ 127.7 %
+ 41.6 %
+ 64.5 %
+ 22.5 %
To 05/03/2026
Calendar Year Performance 2016Calendar Year Performance 2017Calendar Year Performance 2018Calendar Year Performance 2019Calendar Year Performance 2020Calendar Year Performance 2021Calendar Year Performance 2022Calendar Year Performance 2023Calendar Year Performance 2024Calendar Year Performance 2025
+ 1.4 %
+ 4.0 %
- 14.8 %
+ 23.9 %
+ 32.8 %
+ 3.2 %
- 18.9 %
+ 18.0 %
+ 24.1 %
+ 17.3 %
Net Asset Value
358.39 €
Asset Under Management
4 605 M €
Net Equity Exposure30/01/2026
86.3 %
SFDR - Fund Classification
Article
8
Data as of: Jan 30, 2026.
Data as of: Mar 5, 2026.
?Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. The SFDR classification of the Funds may change over time.
Carmignac Investissement fund performance
Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.
Our monthly comments
Data as of: Feb 27, 2026.Fund management team
Performance commentary
- In February, the fund posted a marked underperformance relative to its reference indicator.
- The fund was hurt by sharp market moves targeting perceived “AI losers,” particularly in software and financials. Atlassian and S&P Global were among the largest detractors.
- Doximity, a strategic healthcare partner offering purpose-built solutions to support the industry’s modernization, with more than 80% of U.S. physicians on its platform, was also impacted by these fears.
- Most of these positions have been built in recent weeks and months on the contrarian view that the market may be too quick to judge the true winners and losers of AI.
- Novo Nordisk was also a detractor from performance.
- However, the very strong performance of Korea, and to a lesser extent Taiwan, provided meaningful support to overall returns.
Outlook strategy
- While headline indices appear relatively stable, underlying dispersion is extreme. Significant winners and losers are offsetting each other, even as several large stocks remain under pressure. We expect this environment to persist.
- The “sell first, ask questions later” dynamic has repeated over recent weeks, with a clear target: perceived “AI losers,” particularly in software.
- We actively manage our tech exposure. While hyperscaler exposure is becoming more selective amid an AI capex arms race and rising dispersion, we maintain positions in high-quality semiconductors (including Nvidia and Asian players) as well as in software.
- In software, we believe AI will more likely be deployed on top of existing stacks rather than replacing them. Most enterprises still lack clean, unified, “AI-ready” data, and privacy, security, and compliance challenges remain significant for third-party agents at scale.
- Beyond tech, we aim to use corrections not driven by fundamentals to initiate new positions or reinforce existing ones.
- We maintain meaningful exposure to financials, which benefit from several trends including a pickup in M&A activity, bond and equity volatility, and opportunities among companies wrongly perceived as AI casualties.
Performance Overview
Data as of: Mar 5, 2026.?Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
From 01/01/2013 the equity index reference indicators are calculated net dividends reinvested.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 07/03/2026
Carmignac Investissement Portfolio overview
Below is an overview of the composition of the portfolio.
Geographical Breakdown
Data as of: Jan 30, 2026.| North America | 56.7 % |
| Asia | 26.2 % |
| Europe | 14.3 % |
| Latin America | 1.9 % |
| Asia-Pacific | 0.7 % |
| Eastern Europe | 0.3 % |
To Access the weekly view
Key figures
Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.
Exposure Data
Data as of: Jan 30, 2026.Equity Investment Weight96.6 %
Net Equity Exposure86.3 %
Number of Equity Issuers79
Active Share77.5 %
To Access the weekly view
The strategy in a nutshell
Discover the Fund’s main features and benefits through the words of the Fund Manager.
Fund Management Team
Since its creation in 1989 by Edouard Carmignac, our Investissement strategy seeks to identify long-term trends in a changing world and seize global equity market opportunities.
Articles that may interest you
![[Background image] [CI] Blue sky and buildings](https://carmignac.imgix.net/uploads/NextImage/0001/05/CI_WEB.jpg?auto=format%2Ccompress&fit=fill&w=3840)
Strategies insights • February 3, 2026 • English
Carmignac Investissement: Letter from the Fund Manager - Q4 2025
3 minute(s) read
Strategies insights • November 21, 2025 • English
III. Off the beaten path approach of Carmignac Investissement
4 minute(s) read
Did you enjoy the fund page?
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
The Fund is a common fund in contractual form (FCP) conforming to the UCITS Directive under French law.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.
Market environment